Your session is about to expire
← Back to Search
Intervention for Cardiovascular Disease (BRAVE Trial)
BRAVE Trial Summary
This trial is testing whether bariatric surgery (weight loss surgery) is better than medical weight management (diet and lifestyle changes) for people with high-risk cardiovascular disease.
- Cardiovascular Disease
- Obesity
BRAVE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BRAVE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research project seeking participants currently?
"The clinical trial is still in the process of recruiting patients, as evidenced by its listing on clinicialtrials.gov which was created on October 30th 2020 and updated last March 14th 2022."
What is the overall participation figure for this clinical research?
"Confirmative. According to clinicaltrials.gov, this research is currently recruiting patients who meet the eligibility criteria; it was launched on October 30th 2020 with its latest update occurring in March 14th 2022. The trial requires 60 participants at a single site."
What anticipated results is the research team hoping to achieve?
"The primary evaluation of this trial is focused on the recruitment rate over 30 days. Secondary outcomes are changes in BMI and weight at 1 year, as well as a composite measure encompassing cardiovascular mortality, myocardial infarction (MI), stroke and hospitalization for heart failure (HF)."
Share this study with friends
Copy Link
Messenger